These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Topical use of 5-fluorouracil. Johnson A Med J Aust; 1973 Jun; 1(23):1164. PubMed ID: 4725451 [No Abstract] [Full Text] [Related]
65. [Value of the use of a 5-fluorouracil ointment in the treatment of basal cell epitheliomas in the aged]. Gueguen MH Bull Soc Fr Dermatol Syphiligr; 1971; 78(6):614-5. PubMed ID: 5161912 [No Abstract] [Full Text] [Related]
67. [On the treatment of superficial neoplasms with 5-FU ointment. Preliminary review]. Bergonzini R; Vaccari R; Zagnoli P G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):78-9. PubMed ID: 5467619 [No Abstract] [Full Text] [Related]
68. [Topical treatment of basocellular epitheliomas with 5-fluorouracil and vinblastine. Radiobiologic evaluation and comparison with its status with radiotherapy]. Abad Iglesias R; Perez Palencia M Actas Dermosifiliogr; 1974; 65(7-8):381-7. PubMed ID: 4455059 [No Abstract] [Full Text] [Related]
69. [5-fluorouracil ointment in the treatment of basal cell epithelioma]. Chodynicka B; Szarmach H Przegl Dermatol; 1976; 63(5):691-7. PubMed ID: 1005763 [No Abstract] [Full Text] [Related]
70. [Efudix therapy of extensive basal cell carcinomas]. Kovacs L Z Hautkr; 1980 Jun; 55(12):834-6. PubMed ID: 7415365 [No Abstract] [Full Text] [Related]
71. Giant basal cell carcinoma: an old but effective therapy with 5FU. Persechino S; Caperchi C; Alhadeff A; Fatuzzo G; Persechino F; Tammaro A Eur J Dermatol; 2011; 21(2):287. PubMed ID: 21411415 [No Abstract] [Full Text] [Related]
72. [In actinic keratosis and basal cell carcinoma. The power of light heals without scars]. Stiefelhagen P MMW Fortschr Med; 2003 Mar; 145(13):10. PubMed ID: 15101524 [No Abstract] [Full Text] [Related]
73. Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma. Klein E; Stoll HL; Milgrom H; Traenkle HL; Graham S; Helm F J Invest Dermatol; 1966 Aug; 47(1):22-6. PubMed ID: 25622345 [TBL] [Abstract][Full Text] [Related]
74. Topical antimetabolites. Zackheim HS; Farber EM Annu Rev Med; 1970; 21():59-66. PubMed ID: 4912477 [No Abstract] [Full Text] [Related]
75. Hypertrophic scarring as a complication of fluorouracil therapy. Kaplan LA; Walter JF; Macknet KD Arch Dermatol; 1979 Dec; 115(12):1452. PubMed ID: 533294 [No Abstract] [Full Text] [Related]
76. [Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment]. Ebner H Z Haut Geschlechtskr; 1968 Sep; 43(18):757-62. PubMed ID: 5715906 [No Abstract] [Full Text] [Related]
77. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma. Mohs FE; Jones DL; Bloom RF Arch Dermatol; 1978 Jul; 114(7):1021-2. PubMed ID: 686718 [TBL] [Abstract][Full Text] [Related]
78. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). Kurtis B; Rosen T J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186 [TBL] [Abstract][Full Text] [Related]
79. Tumors of the skin. V. Local administration of anti-tumor agents to multiple superficial basal cell carcinomas. Klein E; Stoll HL; Milgrom H; Traenkle HL; Case RW; Laor Y; Helm F; Nadel RS J Invest Dermatol; 1965 Dec; 45(6):489-95. PubMed ID: 5321314 [No Abstract] [Full Text] [Related]
80. The use of topical 5-fluorouracil in actinic keratoses. Richards RN Can Med Assoc J; 1971 Dec; 105(12):1314-5. PubMed ID: 5150335 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]